X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Strides Arcolab Fact Sheet, Strides Arcolab Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Strides Arcolab Fact Sheet   (PLLB)

Here is the latest financial fact sheet of Strides Arcolab. For more details, see the Strides Arcolab quarterly results and Strides Arcolab share price and chart. For a sector overview, read our pharmaceuticals sector report.

STRIDES SHASUN LTD Price History

Price Rs 826.4
Mkt Cap Rs m 49,295
Vol '000 50.0
P/E X 15.7
P/CF X 11.3
EPS (TTM) Rs 52.7
% ch % 1.1
No. of shares m 59.65
% ch week % 5.7
% ch 1-mth % -2.9
% ch 12-mth % -19.2
52 week H/L Rs 1,259.0/754.0
(As on Nov 21, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STRIDES SHASUN LTD Financials

No. of Mths
Year Ending
12
Dec-12
*
15
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
STRIDES SHASUN LTD EQUITY SHARE DATA
High Rs1,2251,1381,1991,4131,275 
Low Rs372344384848918 
Sales per share (Unadj.) Rs163.6225.1200.6320.3389.6 
Earnings per share (Unadj.) Rs143.9296.6141.713.228.0 
Diluted earnings per shareRs141.9296.2141.719.841.9 
Cash flow per share (Unadj.) Rs149.2306.1152.527.948.9 
Dividends per share (Unadj.) Rs2.00505.00108.005.004.50 
Adj. dividends per shareRs1.97504.32107.957.496.75 
Dividend yield (eoy) %0.368.213.70.40.4 
Book value per share (Unadj.) Rs344.6169.0193.9297.5303.1 
Adj. book value per shareRs339.7168.8193.8445.6454.4 
Shares outstanding (eoy) m58.8059.5759.6289.3589.42 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x4.93.33.93.52.8 
Avg P/E ratio x5.52.55.685.539.2 
P/CF ratio (eoy) x5.42.45.240.522.4 
Price / Book Value ratio x2.34.44.13.83.6 
Dividend payout %1.4170.376.237.816.1 
Avg Mkt Cap Rs m46,95844,13547,165100,98898,036 
No. of employees `0002.71.52.04.75.8 
Total wages/salary Rs m1,2031,5721,7213,5775,881 
Avg. sales/employee Rs Th3,562.18,939.55,979.36,102.86,005.9 
Avg. wages/employee Rs Th445.61,047.9860.3762.71,014.0 
Avg. net profit/employee Rs Th3,134.211,778.34,225.0251.9431.2 
STRIDES SHASUN LTD INCOME DATA
Net Sales Rs m9,61813,40911,95928,62234,834 
Other income Rs m3426023869211,686 
Total revenues Rs m9,96014,01212,34429,54336,520 
Gross profit Rs m1,0062,2342,2894,1406,428 
Depreciation Rs m3095656401,3131,872 
Interest Rs m7951,0894741,6822,269 
Profit before tax Rs m2451,1831,5602,0673,973 
Minority Interest Rs m-11-6600 
Prior Period Items Rs m000-474 
Extraordinary Inc (Exp) Rs m8,34019,7368,361-414-1,006 
Tax Rs m1123,2451,476425470 
Profit after tax Rs m8,46217,6678,4501,1812,501 
Gross profit margin %10.516.719.114.518.5 
Effective tax rate %45.5274.394.620.511.8 
Net profit margin %88.0131.870.74.17.2 
STRIDES SHASUN LTD BALANCE SHEET DATA
Current assets Rs m14,10913,08614,44735,14938,165 
Current liabilities Rs m17,9737,07410,02218,92030,402 
Net working cap to sales %-40.244.837.056.722.3 
Current ratio x0.81.81.41.91.3 
Inventory Days Days16848637877 
Debtors Days Days18399112132104 
Net fixed assets Rs m15,6795,5068,40035,68237,639 
Share capital Rs m588596596894894 
"Free" reserves Rs m18,0394,59410,96225,68526,210 
Net worth Rs m20,26210,06811,55826,57927,105 
Long term debt Rs m7,3122,7552,53026,27016,377 
Total assets Rs m47,97520,99024,80574,55981,168 
Interest coverage x1.32.14.32.22.8 
Debt to equity ratio x0.40.30.21.00.6 
Sales to assets ratio x0.20.60.50.40.4 
Return on assets %19.389.436.03.85.9 
Return on equity %41.8175.573.14.49.2 
Return on capital %34.0171.673.86.212.1 
Exports to sales %53.059.460.253.10 
Imports to sales %15.720.523.515.90 
Exports (fob) Rs m5,0997,9597,20415,1920 
Imports (cif) Rs m1,5152,7522,8094,5650 
Fx inflow Rs m6,48222,79113,03116,61213,465 
Fx outflow Rs m1,8263,0883,1655,2924,076 
Net fx Rs m4,65619,7039,86511,3209,389 
STRIDES SHASUN LTD CASH FLOW
From Operations Rs m 1,343 -2,717 834 733 2,881 
From Investments Rs m 8,065 40,771 519 -22,248 -7,051 
From Financial Activity Rs m -9,900 -33,185 -4,213 29,439 3,382 
Net Cashflow Rs m -492 4,869 -2,860 7,924 -788 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 27.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 37.8%
FIIs 8.6%
ADR/GDR 0.0%
Free float 25.9%
Shareholders 56,241
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 705
E-MAIL badree.komandur@stridesarco.com WEB www.stridesarco.com
TELEPHONE (080) 6784 0000 FAX (080) 6784 0800
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Deepak Vaidya (MD) COMP SEC: Badree Komandur (EVP-Finance) YEAR OF INC: 1980 BSE CODE: 532531 FV (Rs): 10 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   IPCA LABS  GLENMARK PHARMA  CADILA HEALTHCARE  NOVARTIS  GSK PHARMA  

Compare STRIDES SHASUN LTD With:   IPCA LABS  GLENMARK PHARMA  CADILA HEALTHCARE  NOVARTIS  GSK PHARMA  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Firm Note; Tech Mahindra Gains 3.3%(Closing)

Indian share markets continued to trade well above the dotted line in the afternoon session and finished in green for fourth consecutive day. At the closing bell, the BSE Sensex closed higher by 119 points

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

'Buy and Hold Forever' Not The Best Investing Style After All(The 5 Minute Wrapup)

Nov 9, 2017

Even Buffett didn't always Buy and Hold forever. A look at Berkshire's 1992 and 2017 portfolios will tell you the story...

Of Falling Real Estate Prices, Dr Arvind Panagariya and the Art of Continuing to Suck Up(Vivek Kaul's Diary)

Nov 13, 2017

Dr Panagariya claims real estate prices have fallen 25 per cent post demonetisation; the official data doesn't show anything like that.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

You're Lucky You Missed Out on that IPO...(Smart Contrarian)

Nov 8, 2017

Here's how to profit from upcoming IPOs.

Why I am the Biggest India Equity Bull on Planet Earth!(The Honest Truth)

Nov 16, 2017

If you have a dream, dream big...about the level of BSE 30 index in 2050!

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - BIOCON LTD COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS